Sign inJoin waitlistJoin the waitlist

RE

Reginald Ewesuedo

Clinical Pharmacology

Credentials: ·

History

Pediatric Hematology Oncology
University of Chicago Medical Center
1996–1999
Pediatrics
Children's Hospital of Michigan
1993–1996
Medical School
1989–1993
University of Ibadan
1980–1983

Research

A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumors
Investigational New Drugs · 2026 · Last of 14 authors · Corresponding · 1 citations
Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With…
Clinical Lung Cancer · 2025 · 1 citations
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial
Cancer Chemotherapy and Pharmacology · 2026 · Last of 6 authors · Corresponding

Daruka Mahadevan
2 papers
JP
Jay Parekh
2 papers
Anthony Olszanski
1 paper
BB
Bruce Bank
1 paper
JB
J Beck
1 paper
JS
Janakiraman Subramanian
1 paper
JH
John Hamm
1 paper
Jonathan Dowell
1 paper
JT
Joseph Treat
1 paper
KS
Kamlesh Sankhala
1 paper
KS
Karisa Schreck
1 paper
Kartik Konduri
1 paper